Training Portal BioMedraRA

In our continuous endeavor to contribute to the field of research, BioMedraRA provides world class “Training” to professionals in the related field, in order to build and hone their skills and make them job ready for clinical research.

Experienced Team
Our group has a collective experience of more than 30 years in US, Canada & India into numerous domains of healthcare & science, education and training hundreds of aspirants. Over these past years, we have persistently understood the gap amongst the industry requirements and lack in the opportunities and understanding of an applicant for a perkier future. Our vibrant training team and coordinators are passionate to bring a major makeover in your career by sharing their understanding, considerations and opportunities in form of training courses

Advantage BioMedRA
Our exclusive blend of understanding & experience, propositions an intrinsic gain to our candidate. Right from admission till employment we support them in following ways:

  • Quality Curriculum designed by Industry Experts
  • Smooth Enrolment & Completion
  • 100% Placement Support
  • Secured Payment routes
  • Pay-in-Instalments Substitute
  • Professionals Networking with Industry Gurus
  • Economical Course Fee
  • Employment Oriented Programs

Clinical Research Overview – Global Perspective
The value of global clinical research business is assessed to US$ 65 billion with more than 160000 clinical trials being conducted till date (source: clinicaltrail.gov). As United States account 41% of the total studies, the attention is shifting to countries like India, Russia, Brazil, China due to greater patient pool & higher enrolment rate, low price, enhanced infrastructures, high number of hospital and medical specialists.

Clinical Research – Indian Perspective
With numerous resource advantages and changing mind sets, India has emerged as the preferred destination for Clinical Trials. After India became a signatory of intellectual property regimen of WTO, Clinical Trials Industry has seen a multi-fold increase in the past 10 years or so. The charts & figures below give a snapshot of how this industry has progressed in India over a period of time.

Fig 1. Number of global trials and the proportion in India. Source: The Boston Consulting Group and Business Communications Company data quoted in Mishra

Figure 2: Number of trials and patients in India. The Boston Consulting Group and Business Communications Company data quoted in Mishra

 

Figure 3: Financial growth of clinical trials industry in India. Source: Vasireddi

Figure 4: Most attractive locations for future foreign R & D in UNCTAD survey, 2005–2009 (percent of responses).

 

INDIA - Resource advantages as destination for clinical trials.

Investigators

  • Large no. of specialists in different therapy segments
  • Medical training in English
  • 600,000 English speaking physicians
  • PG training from Europe/US
  • Treatment protocols in line with west
  • Large no. of ICH/GCP complaint investigators/sites

Patient population

  • Large, diverse, therapy-naïve
  • Advantage of having 6 out of 7 genetic varieties
  • Large pt. pool in acute/chronic disease segment
  • Increasing no. of pts in life style disorders segment, HIV, oncology

Clinical research infrastructure

  • Over 200 medical colleges
  • Over 22,000 graduates per year
  • 15,622 hosp., 903,952 hosp. beds >75% in urban area
  • 14000 diagnostic labs
  • 700,000 scientists and engineering graduates/year
  • World class medical/lab facilities at secondary/tertiary care centres
  • Skilled computer savvy biomedical work force

IT support

  • Highly developed IT/ITES
  • Motivated and committed personnel

Connectivity

  • High quality digital connectivity
  • Excellent air/surface transport facilities across country


~Source: Surender Singh

Job Prospects
Following positions are open to pursuit as profession in Clinical Research:

News & Updates

Pharmacovigilance Market Is Anticipated to Be Worth $5.51 Billion By 2020: Latest Report By Grand View Research, Inc.
readmore...